Age of Red Cells for Transfusion and Outcomes in Critically Ill Adults

Age of Red Cells for Transfusion and Outcomes in Critically Ill Adults

The age of transfused red cells did not affect 90-day mortality among critically ill adults. In an international, multicenter, randomized, double-blind trial, we assigned critically ill adults to receive either the freshest... read more

Probiotics Offer Powerful Protection Against Sepsis in Infants

Probiotics Offer Powerful Protection Against Sepsis in Infants

Sepsis can occur in just about anyone, including infants. Recent research shows feeding newborns probiotics (healthy bacteria) significantly lowers the child's risk of developing sepsis. The study involved infants in rural... read more

Antimicrobials for the Treatment of Drug-Resistant Acinetobacter Baumannii Pneumonia in Critically Ill Patients

Antimicrobials for the Treatment of Drug-Resistant Acinetobacter Baumannii Pneumonia in Critically Ill Patients

This Bayesian network meta-analysis demonstrated the comparative effectiveness of fifteen antimicrobial treatments for drug-resistant A. baumannii pneumonia in critically ill patients. For survival benefit, SUL appears to... read more

Urine Test Developed to Test for Tuberculosis

Urine Test Developed to Test for Tuberculosis

An international team of researchers has developed a urine test that can be used to detect tuberculosis (TB) in human patients. Alessandra Luchini and her team have developed a urine test for TB that gives results in 12 hours.... read more

Effect of Boarding on Mortality in ICUs

Effect of Boarding on Mortality in ICUs

Mortality increased with boarding of critically ill patients. Further research is needed to identify safer practices for managing patients during periods of high ICU occupancy. The study population consisted of 8,429 patients... read more

Clinicians’ Expectations of the Benefits and Harms of Treatments, Screening, and Tests

Clinicians’ Expectations of the Benefits and Harms of Treatments, Screening, and Tests

Clinicians rarely had accurate expectations of benefits or harms, with inaccuracies in both directions. However, clinicians more often underestimated rather than overestimated harms and overestimated rather than underestimated... read more

Fifty Years of Research in ARDS

Fifty Years of Research in ARDS

Mechanical ventilation (MV) is critical in the management of many patients with acute respiratory distress syndrome (ARDS). However, MV can also cause ventilator-induced lung injury (VILI). The selection of an appropriate... read more

A Research Agenda for Communication Between Health Care Professionals and Patients Living With Serious Illness

A Research Agenda for Communication Between Health Care Professionals and Patients Living With Serious Illness

Poor communication by health care professionals contributes to physical and psychological suffering in patients living with serious illness. Patients may not fully understand their illness, prognosis, and treatment options... read more

Top 10 Critical Care Trials for 2017

Top 10 Critical Care Trials for 2017

We held a poll within our editorial group, rating all 36 of the published trials from 2017 that we have summarised and critiqued. We considered the importance of the clinical question, how game changing the conclusion was... read more

How Big Tech Is Going After Your Health Care

How Big Tech Is Going After Your Health Care

When Daniel Poston, a second-year medical student in Manhattan, opened the App Store on his iPhone a couple of weeks ago, he was astonished to see an app for a new heart study prominently featured. People often learn about... read more

Endoscopic Treatment versus Shunting for Hydrocephalus

Endoscopic Treatment versus Shunting for Hydrocephalus

In sub-Saharan Africa, a large number of infants are affected by hydrocephalus that develops after neonatal ventriculitis and is often associated with poor developmental outcomes. New research findings are summarized in a... read more

FDA Approves Angiotensin-II for Septic Shock

FDA Approves Angiotensin-II for Septic Shock

The FDA approved angiotensin-II (Giapreza) as a new intravenous vasopressor for septic shock and other forms of distributive shock. The first new FDA-approved vasopressor in decades, angiotensin-II could significantly change... read more

Optimizing Quality and Efficiency of Critical Care Delivery

Optimizing Quality and Efficiency of Critical Care Delivery

Providing "health" care is expensive, and providing "sick" care is even more expensive. Here we will outline a newly packaged, high-yield opportunity for your institution regarding optimization of your critical care service... read more

Guidelines for the Content of Statistical Analysis Plans in Clinical Trials

Guidelines for the Content of Statistical Analysis Plans in Clinical Trials

While guidance on statistical principles for clinical trials exists, there is an absence of guidance covering the required content of statistical analysis plans (SAPs) to support transparency and reproducibility. Recommendations... read more